DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,121,084,260 | +3.5% | 4,518,679 | +0.2% | 4.94% | +13.1% |
| Q2 2023 | $1,082,725,680 | +31.8% | 4,511,357 | +38.4% | 4.37% | +26.5% |
| Q1 2023 | $821,419,279 | +20.9% | 3,259,083 | +27.4% | 3.46% | +33.2% |
| Q4 2022 | $679,249,858 | +3.6% | 2,559,151 | +0.8% | 2.59% | +7.4% |
| Q3 2022 | $655,789,000 | -5.8% | 2,538,963 | -7.5% | 2.42% | +3.4% |
| Q2 2022 | $696,030,000 | -3.3% | 2,745,462 | +11.9% | 2.34% | +16.2% |
| Q1 2022 | $719,596,000 | +50.0% | 2,453,197 | +68.2% | 2.01% | +55.5% |
| Q4 2021 | $479,816,000 | +42.0% | 1,458,362 | +31.4% | 1.29% | +31.4% |
| Q3 2021 | $337,815,000 | +14.1% | 1,109,626 | +0.6% | 0.98% | +11.1% |
| Q2 2021 | $296,029,000 | +14.9% | 1,103,104 | -3.7% | 0.89% | -2.4% |
| Q1 2021 | $257,699,000 | +47.5% | 1,144,920 | +45.6% | 0.91% | +27.0% |
| Q4 2020 | $174,688,000 | -21.5% | 786,385 | -23.9% | 0.72% | -34.1% |
| Q3 2020 | $222,476,000 | +15.8% | 1,033,185 | -4.9% | 1.08% | +8.4% |
| Q2 2020 | $192,046,000 | +25.6% | 1,086,051 | -1.7% | 1.00% | -2.6% |
| Q1 2020 | $152,913,000 | -31.1% | 1,104,786 | -23.6% | 1.03% | -31.8% |
| Q4 2019 | $222,056,000 | +14.6% | 1,446,805 | +7.9% | 1.51% | -2.3% |
| Q3 2019 | $193,715,000 | +6.5% | 1,341,241 | +5.4% | 1.54% | -1.0% |
| Q2 2019 | $181,860,000 | -21.5% | 1,272,461 | -27.5% | 1.56% | -26.9% |
| Q1 2019 | $231,736,000 | -55.8% | 1,755,311 | -65.5% | 2.13% | -57.2% |
| Q4 2018 | $524,417,000 | -15.8% | 5,085,500 | -11.2% | 4.99% | -12.2% |
| Q3 2018 | $622,603,000 | +13.7% | 5,729,830 | +3.2% | 5.69% | +5.9% |
| Q2 2018 | $547,655,000 | -0.4% | 5,549,805 | -1.2% | 5.37% | -4.7% |
| Q1 2018 | $549,710,000 | -12.4% | 5,614,445 | -17.0% | 5.63% | -6.1% |
| Q4 2017 | $627,881,000 | +8.0% | 6,764,501 | -0.2% | 6.00% | -1.0% |
| Q3 2017 | $581,324,000 | +19.1% | 6,776,921 | +17.2% | 6.06% | +9.1% |
| Q2 2017 | $487,945,000 | +42.8% | 5,782,019 | +44.7% | 5.56% | +6.1% |
| Q1 2017 | $341,796,000 | +16.7% | 3,996,209 | +6.2% | 5.24% | +10.3% |
| Q4 2016 | $292,790,000 | +11.8% | 3,761,439 | +12.6% | 4.75% | +8.7% |
| Q3 2016 | $261,918,000 | +13.5% | 3,341,211 | +46.3% | 4.37% | +10.2% |
| Q2 2016 | $230,692,000 | -10.9% | 2,284,077 | -16.3% | 3.96% | -3.8% |
| Q1 2016 | $258,803,000 | +57.1% | 2,728,263 | +53.9% | 4.12% | +46.7% |
| Q4 2015 | $164,704,000 | +16.2% | 1,773,297 | +6.6% | 2.81% | +13.9% |
| Q3 2015 | $141,722,000 | +195.5% | 1,663,207 | +196.8% | 2.47% | +166.0% |
| Q2 2015 | $47,965,000 | – | 560,407 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |